Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia . (27th October 2021)
- Record Type:
- Journal Article
- Title:
- Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia . (27th October 2021)
- Main Title:
- Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia
- Authors:
- Manning, Jessica E
Chea, Sophana
Parker, Daniel M
Bohl, Jennifer A
Lay, Sreyngim
Mateja, Allyson
Man, Somnang
Nhek, Sreynik
Ponce, Aiyana
Sreng, Sokunthea
Kong, Dara
Kimsan, Soun
Meneses, Claudio
Fay, Michael P
Suon, Seila
Huy, Rekol
Lon, Chanthap
Leang, Rithea
Oliveira, Fabiano - Abstract:
- Abstract: Background: We established the first prospective cohort to understand how infection with dengue virus is influenced by vector-specific determinants such as humoral immunity to Aedes aegypti salivary proteins. Methods: Children aged 2–9 years were enrolled in the PAGODAS (Pediatric Assessment Group of Dengue and Aedes Saliva) cohort with informed consent by their guardians. Children were followed semi-annually for antibodies to dengue and to proteins in Ae . aegypti salivary gland homogenate using enzyme-linked immunosorbent assays and dengue-specific neutralization titers. Children presented with fever at any time for dengue testing. Results: From 13 July to 30 August 2018, we enrolled 771 children. At baseline, 22% (173/770) had evidence of neutralizing antibodies to 1 or more dengue serotypes. By April 2020, 51 children had symptomatic dengue while 148 dengue-naive children had inapparent dengue defined by neutralization assays. In a multivariate model, individuals with higher antibodies to Ae . aegypti salivary proteins were 1.5 times more likely to have dengue infection (hazard ratio [HR], 1.47 [95% confidence interval {CI}, 1.05–2.06]; P = .02), particularly individuals with inapparent dengue (HR, 1.64 [95% CI, 1.12–2.41]; P = .01). Conclusions: High levels of seropositivity to Ae. aegypti salivary proteins are associated with future development of dengue infection, primarily inapparent, in dengue-naive Cambodian children. Clinical Trials Registration:Abstract: Background: We established the first prospective cohort to understand how infection with dengue virus is influenced by vector-specific determinants such as humoral immunity to Aedes aegypti salivary proteins. Methods: Children aged 2–9 years were enrolled in the PAGODAS (Pediatric Assessment Group of Dengue and Aedes Saliva) cohort with informed consent by their guardians. Children were followed semi-annually for antibodies to dengue and to proteins in Ae . aegypti salivary gland homogenate using enzyme-linked immunosorbent assays and dengue-specific neutralization titers. Children presented with fever at any time for dengue testing. Results: From 13 July to 30 August 2018, we enrolled 771 children. At baseline, 22% (173/770) had evidence of neutralizing antibodies to 1 or more dengue serotypes. By April 2020, 51 children had symptomatic dengue while 148 dengue-naive children had inapparent dengue defined by neutralization assays. In a multivariate model, individuals with higher antibodies to Ae . aegypti salivary proteins were 1.5 times more likely to have dengue infection (hazard ratio [HR], 1.47 [95% confidence interval {CI}, 1.05–2.06]; P = .02), particularly individuals with inapparent dengue (HR, 1.64 [95% CI, 1.12–2.41]; P = .01). Conclusions: High levels of seropositivity to Ae. aegypti salivary proteins are associated with future development of dengue infection, primarily inapparent, in dengue-naive Cambodian children. Clinical Trials Registration: NCT03534245 Abstract : Results from a longitudinal pediatric cohort in Cambodia demonstrated that children with high levels of antibodies to Aedes aegypti mosquito saliva were more likely to get dengue, but were also less likely to have clinical symptoms. … (more)
- Is Part Of:
- Journal of infectious diseases. Volume 226:Number 8(2022)
- Journal:
- Journal of infectious diseases
- Issue:
- Volume 226:Number 8(2022)
- Issue Display:
- Volume 226, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 226
- Issue:
- 8
- Issue Sort Value:
- 2022-0226-0008-0000
- Page Start:
- 1327
- Page End:
- 1337
- Publication Date:
- 2021-10-27
- Subjects:
- Aedes aegypti -- Cambodia -- dengue -- mosquito saliva -- pediatric cohort
Communicable diseases -- Periodicals
Diseases -- Causes and theories of causation -- Periodicals
Medicine -- Periodicals
Communicable Diseases -- Periodicals
Electronic journals
616.9 - Journal URLs:
- http://jid.oxfordjournals.org/content/by/year ↗
http://www.journals.uchicago.edu/JID/journal/ ↗
http://www.jstor.org/journals/00221899.html ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/infdis/jiab541 ↗
- Languages:
- English
- ISSNs:
- 0022-1899
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24083.xml